SCHEMBL6949864

SCHEMBL6949864

CSc1nc(OCCCc2ccccn2)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.36
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HTT P42858 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
FKBP1A P62942 1/20 0.33
HRH1 P35367 1/20 0.33
HTR6 P50406 1/20 0.33
IDH1 O75874 3/20 0.33
CASP1 P29466 1/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949790 0.84 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6953029 0.84 GRM2 (0.40) HRH4ALDH1A1KDM4EHPGDMAPT
SCHEMBL6947632 0.81 PIK3CD (0.39) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6954683 0.80 TYK2 (0.35) HRH4ALDH1A1KDM4EHPGDMAPT
SCHEMBL6955735 0.80 ADRA2A (0.38) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6949089 0.80 MKNK1 (0.40) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6949293 0.78 MEN1 (0.39) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6956595 0.73 KMT2A (0.45) HRH4ALDH1A1KDM4EHPGDMAPT
SCHEMBL6948665 0.73 KDM4E (0.48) ALDH1A1KDM4EHPGDMAPTHSD17B10
SCHEMBL6948352 0.72 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed